MAP2K5 and non-small cell lung carcinoma: Collectively, these results confirmed that glutamine metabolism in NSCLC activates the FGF17/MEK5/ERK5/NRF2 signaling pathway via GLUL, thereby lowering oxidative stress levels in the tumor microenvironment and enhancing migratory and invasive capacities of tumor cells.